On May 10, 2019, the Food and Drug Administration approved ramucirumab (CYRAMZA®, Eli Lilly and Company) as a single agent for hepatocellular carcinoma (HCC) | Read More

Varian (NYSE: VAR) today announced it has acquired Austin, Texas-based Endocare and Hangzhou, China-based, Alicon, to expand its portfolio of multidisciplinary integrated cancer care solutions. Endocare is a leading provider of hardware and software solutions supporting cryoablation and microwave ablation, and Alicon, a leader in embolic therapy for treating liver cancer in China.   | Read More
In this Q&A, Govindarajan Narayanan, MD, talks with Interventional Oncology 360 about the NanoKnife System and a study that recently received FDA clearance. Dr. Narayanan is coprincipal investigator of the DIRECT clinical study. | Read More
Some patients who undergo selective internal radiotherapy (SIRT) with yttrium-90 (Y-90) may be eligible for liver resection, researchers reported. | Read More

Spotlight

Alda Tam, MD, presents the case of a 60-year-old man with mesothelioma.
Robert Lewandowski, MD, an interventional radiologist and Director of Interventional Oncology at Northwestern University Feinberg School of Medicine in Chicago, describes the rationale for radiation lobectomy, as well as recent advances and practical tips.
Dan Brown, MD, shows case examples demonstrating timing of Y-90 therapy and personalizing therapy to the patient's biology.